SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Evan Dimmer who wrote (5444)2/12/1998 12:18:00 PM
From: Zebra 365  Read Replies (1) of 23519
 
Evan you are correct. Volume drying up means that either there is not much supply or there is not much demand at this price. Money is neither flowing in or out of the claims on equity that the stock represents.

I think there is little stock offered because the large holders know that MCA approval could cause a 30% jump in price in a day.

I think there is little demand for the stock because of the prior demonstrated risk, and the fact that MCA approval is uncertain and will have a huge effect on this quarter's earnings.

This is not a good short position to enter, given the fundamentals of the business. And there is not particular pressure to cover, (also I believe short interest as of Feb 15th will be lower than Jan 15th).

IMHO, it is the calm before the storm. And I own the stock because I think the price movement will be upward when the storm comes.

Zebra

PS Two patient inquiries generated from Ladies Home Journal, none from Wall Street Journal so far.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News